Understanding the cell structure of the retina in age-related macular degeneration
Deconstructing and Modeling the Single Cell Architecture of the Age-Related Macular Degeneration Retina and RPE/Choroid
This study is looking at the different types of cells in the eyes of people with age-related macular degeneration (AMD) to better understand how the disease affects vision, with the hope of finding ways to improve treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10674702 on NIH RePORTER |
What this research studies
This research investigates the complex architecture of the retina and the retinal pigment epithelium (RPE) in patients with age-related macular degeneration (AMD). By utilizing advanced techniques like single-cell RNA sequencing, the study aims to identify and characterize the various cell types involved in AMD. Collaborating with the Alabama Eye Bank, researchers will analyze human retinal cells to gain insights into the disease's progression and its impact on vision. This work seeks to bridge the gap between genetic findings and clinical applications, ultimately improving our understanding of AMD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with age-related macular degeneration, particularly those experiencing vision loss.
Not a fit: Patients with other forms of vision impairment unrelated to age-related macular degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnostic tools and treatments for age-related macular degeneration, potentially preserving vision for many patients.
How similar studies have performed: Previous research utilizing single-cell RNA sequencing has shown promise in understanding complex diseases, suggesting that this approach could yield valuable insights into AMD.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Stambolian, Dwight Edward — University of Pennsylvania
- Study coordinator: Stambolian, Dwight Edward
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.